FindTrial
Sign In

A study comparing two numbing medicines used with laser to reduce pain during treatment of painful milk teeth in children

Anaesthetic Success Of Laser Assisted Lignocaine And Articaine In Deciduous Molar With Symptomatic Irreversible Pulpitis: A Randomized Comparative Clinical Study - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109086
Enrollment
57
Registered
2026-04-22
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K040- Pulpitis

Interventions

Intervention1: IANB with lignocaine and LLLT: Inferior Alveolar Nerve Block (IANB) using 2% lidocaine with Low-Level Laser Therapy (LLLT), Inferior Alveolar Nerve Block (IANB) using 4% articaine with

Sponsors

Dr Rahul Solanki
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Children, aged between 4 to 8 years. 2. Symptomatic irreversible pulpitis in deciduous second mandibular molars. 3. Teeth with hyperresponsive pulp to thermal/electric pulp testing. 4. No periapical pathology (swelling, or radiolucency). 5. Restorable crown structure of the tooth. 6. Co-operative children who can understand and respond using pain scales (wong-baker faces scale).

Exclusion criteria

Exclusion criteria: 1. Children aged less than 4 or more than 8 years. 2. Asymptomatic teeth. 3. With periapical abscess, internal/external resorption, or pathological mobility. 4. Non-restorable teeth or those that are indicated for extraction. 5. Allergy to any of the local anesthetic drugs used in the study in children. 6. Systemic disease in children. 7. Uncooperative children or having special health care needs or psychological illness. 8. Patients on long-term analgesic or antibiotic treatment. 9. Previous endodontic treatment in the same tooth.

Design outcomes

Primary

MeasureTime frame
To evaluate the success of Inferior Alveolar Nerve Block (IANB) using 2% lidocaine with Low-Level Laser Therapy (LLLT), Inferior Alveolar Nerve Block (IANB) using 4% articaine with Low-Level Laser Therapy (LLLT) and IANB combined with buccal infiltration using 2% lidocaine in mandibular molar with symptomatic irreversible pulpitis.Timepoint: 0-pre treatment 1-during treatment 2-post treatment at the base line—

Secondary

MeasureTime frame
To measure & compare pain perception during access opening & initial instrumentation using the Wong Baker Faces Pain Rating Scale & FLACC scale (face, legs,activities,cry, consolability) in all 3 groups. To evaluate the level of child cooperation & comfort during treatment using houpt behaviour rating scale in each group. To assess whether any intraoperative supplementary infiltration will be needed or not based on Wong Baker Faces Pain Rating Scale. Timepoint: 0-pre treatment 1-during treatment 2-post treatment at base line—

Countries

India

Contacts

Public ContactDR Rahul Solanki

Karnavati School of Dentistry, Karnavati University

drmegha1782@Gmail.com7574074635

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026